from Reuters: Company News https://ift.tt/2Tp6Twm
Biohaven drug wins U.S. FDA approval for use in relieving migraine headaches
The U.S. Food and Drug Administration on Thursday approved Biohaven Pharmaceutical Holding Co Ltd's oral pill for relieving pain after the onset of migraine headaches, the drug developer said.
from Reuters: Company News https://ift.tt/2Tp6Twm
from Reuters: Company News https://ift.tt/2Tp6Twm
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment